Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 74,922 shares at $12.32 ($923K) on 2025-10-06, disclosed to the SEC on 2025-10-08.
Scheduled sale ($923k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.32 | 37,461 | $462K | 50.0% |
| 2 | $12.32 | 37,461 | $462K | 50.0% |
| Total | $12.32 avg | 74,922 | $923K | 100% |
| Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |
| ORIC | SELL | 2024-03-08 | $648K | — | Filing → |